Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria

16 pages, Oct 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Climate change and urbanisation drive growth in the category

Cough, cold and allergy (hay fever) remedies is expected to generate healthy value growth over the forecast period due to the projected declining air quality from climate change and pollution in Algeria. The category is also expected to continue benefiting from rising urbanisation and greater consumer awareness for certain medicines.

Cough, cold and allergy (hay fever) remedies to continue seeing solid growth

The category is likely to continue benefiting from unit price stability due to increasing levels of domestic production from local players such as Saidal Algerie SpA as well as the various international players present in Algeria through joint-ventures, such as Sanofi and Saidal with Winthrop Pharma Saïdal. Furthermore, cough, cold and allergy (hay fever) remedies products are often seen as remedies for minor and fleeting illnesses and Algerian consumers are not generally in the habit of consulting a doctor when faced with such illnesses.

Introduction of local production to support growth over the forecast period

The lack of new product developments in the category, including new formulations, delivery mechanisms and packaging formats, has the potential to pose a threat to the category’s performance over the forecast period. Therefore, it is likely that producers will be forced to rely on sales of existing brands by maintaining low unit prices instead of making attempts to gain new consumers.

COMPETITIVE LANDSCAPE

The Humex brand performs well thanks to its promotion on French television

Saidal Algerie SpA remained the leading player in cough, cold and allergy (hay fever) remedies in 2017. The company manufactures the best-selling brands Humex, Toplexil and Fluimicil under licence.

Better perception of international brands leads to their dominance

International brands manufactured in Algeria dominated sales of cough, cold and allergy (hay fever) remedies in 2017. These brands are often manufactured under licence, including Humex by Saidal Algerie SpA, although some are produced by international companies operating directly in Algeria such as Actifed from GlaxoSmithKline Algérie SpA.

Government struggles to push consumers towards generics

For several years, the Algerian Ministry of Health has attempted to promote domestic production of cough, cold and allergy (hay fever) remedies and, in particular, locally-produced generics, in order to reduce the country’s social security bill, and to promote the quality of domestic production in comparison to imported international brands. However, despite the efforts of retail pharmacists to promote sales of generic medicines, Algerian consumers tend to consider these to be of a lower quality and to be less effective than international brands.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Algeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Algeria, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Algeria market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Algeria?
What are the major brands in Algeria?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria - Category analysis

HEADLINES

PROSPECTS

Climate change and urbanisation drive growth in the category

Cough, cold and allergy (hay fever) remedies to continue seeing solid growth

Introduction of local production to support growth over the forecast period

COMPETITIVE LANDSCAPE

The Humex brand performs well thanks to its promotion on French television

Better perception of international brands leads to their dominance

Government struggles to push consumers towards generics

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Consumer Health in Algeria - Industry Overview

EXECUTIVE SUMMARY

Consumer health performance slows down due to rising generics availability

Growing production of domestic generics encouraged by the government

Local manufacturers of consumer health products reinforce their growing shares during 2017

Chemists/pharmacies remains the dominant distribution channel for consumer health

Growth of consumer health to be sustained by rising domestic product supply

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Climate change and urbanisation drive growth in the category

Cough, cold and allergy (hay fever) remedies to continue seeing solid growth

Introduction of local production to support growth over the forecast period

COMPETITIVE LANDSCAPE

The Humex brand performs well thanks to its promotion on French television

Better perception of international brands leads to their dominance

Government struggles to push consumers towards generics

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria - Category analysis

HEADLINES

PROSPECTS

Climate change and urbanisation drive growth in the category

Cough, cold and allergy (hay fever) remedies to continue seeing solid growth

Introduction of local production to support growth over the forecast period

COMPETITIVE LANDSCAPE

The Humex brand performs well thanks to its promotion on French television

Better perception of international brands leads to their dominance

Government struggles to push consumers towards generics

CATEGORY DATA

Consumer Health in Algeria - Industry Overview

EXECUTIVE SUMMARY

Consumer health performance slows down due to rising generics availability

Growing production of domestic generics encouraged by the government

Local manufacturers of consumer health products reinforce their growing shares during 2017

Chemists/pharmacies remains the dominant distribution channel for consumer health

Growth of consumer health to be sustained by rising domestic product supply

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports